Dr. Peter Attia
speaker
5,258 appearances
36 recordings
6 series
first heard Jan 2024
last heard Jun 2025
Dr. Peter Attia’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
That was a stage four?
This is a median survival study. You're not doing overall survival, correct?
I feel like it was eight more months of median survival. Does that sound about right?
Now, at this point, I'm in medical school just down the street. I'm at Stanford. And I remember we had a big discussion about this. I'm in my first year of medical school. And the discussion we had in class was, I think at the time Avastin was $100,000 for the treatment. Extends median survival by whatever, but I think it was eight months.
The UK said, no, the NHS said, we are not paying for this because at the time the NHS had this $100,000 quality adjusted life year hurdle, which is understandable, right? That's how you throttle supply side economics. They said, look, we can't pay for a drug. We can't pay more than $100,000 for an incremental year of quality adjusted life year. This is only giving you eight months.
That's why I know it was less than 12. And so the NHS flatly said, we're not paying for this. And I do believe people in the UK could pay out of pocket for it.
That's right. People in Canada could not because you couldn't have private insurance in Canada, though you could come to the US for treatment. So of course, this just became a great topic of discussion for med school freshmen. What was your thought at the time of, have we moved the needle enough? How do we think about the economics of this?
Did you go straight from Genentech to being a chancellor at UCSF? Just because I want to stay with the story, I want to continue the arc of your career. We're at the halfway point, right? We're one third of the way into- Early days. Yeah, yeah, yeah.
How did you, given you are truly on the cusp of what is happening in oncology and biotechnology, and now the same institution that said- you can't come back here to have a clinical appointment after saving the people of Uganda is now offering you the highest post essentially outside of a provost, I'm guessing, right? I don't even know where the chance- It is the highest post.
It is the highest post. Okay. So that's kind of remarkable. And does that just speak to what they saw as the vision of that institution, which was few people have learned what Sue has learned in the last 10 years, and we want that type of leadership here?
That's right. That was 99?
Oh my God. Okay. I'm off by a whole decade. I thought that was sooner.
It was a- It's a hostile takeover. A hostile takeover.
No, I don't.
And that was starting in the 80s?
Of Nobel fame.
I'm sure that when you're going through that, sorry to interrupt, because you're now interviewing with the Board of Trustees.
Yeah. And so they must be asking you to present a vision. They're not interviewing you to make sure you know how to use PowerPoint. Yeah. Do you remember what the vision is that you presented to them?
You were the president. What was your title at Genentech before you left? President. Yeah, yeah.
My kind of guy. Yeah.
Showing 841–860 of 5,258 · page 43 of 263
← Previous
Next →